List Title | APhA DrugInfoLine

Psychiatry

SORT BY: Most Recent Most Viewed

January 28, 2019

Off-label use of antipsychotics should be done cautiously in children

READ

PREVIEW
Children and young adults aged 5 years to 24 years who were prescribed higher doses of antipsychotics were found to be at a 1.8-times higher risk of death from any cause, 3.5-times higher risk of...
December 18, 2018

Antipsychotics not useful for ICU delirium

READ

PREVIEW
I.V. boluses of haloperidol or ziprasidone were not effective for management of patients with hypoactive or hyperactive delirium in the ICU compared with placebo, according to results of a trial...
December 11, 2018

Quetiapine prescribing decreased after clinicians received Medicare letters

READ

PREVIEW
High-volume primary care prescribers of quetiapine who received letters stating their use of the drug was higher than their peers and was under review by Medicare resulted in less prescribing of...
November 27, 2018

Medications used for substance abuse disorders may reduce suicidality, crime

READ

PREVIEW
Use of medications for alcohol or opioid abuse (e.g., naltrexone, buprenorphine, methadone) was associated with reductions in accidental overdoses, suicidal behaviors, and crime, according to...
September 25, 2018

Unsafe use of zolpidem is common

READ

PREVIEW
An assessment of national survey data from 2015 showed that many patients used zolpidem in unsafe ways, such as by administering higher-than-recommended doses (females and older adults), using the...

Pages

Medication Monitor

RSS Follow Medication Monitor on Twitter Follow APhA Druginfoline on Twitter

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.